Create
Query
event_store.db
—
events
actions
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row 22291 in events
seq
Primary key.
INTEGER
id
evt_0eae314ab40e
TEXT NOT NULL
kind
signal_ingest
TEXT NOT NULL
ts
2026-04-11T09:05:02.498104+00:00
TEXT NOT NULL
actor
daemon:signal_enrichment
TEXT
subject_entity_ids
[]
TEXT
payload
{"created_at":"2026-04-11T03:10:51.104915+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:5f1a2e291704cfb5","evidence_event_ids":["evt_f805dc39f6b0"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1802768/0001140361-26-014241.txt","as_of":"2026-04-11T03:10:51.104915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1802768/0001140361-26-014241.txt","company":"Royalty Pharma plc","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1802768/0001140361-26-014241.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_2bce81754a191def","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1802768/0001140361-26-014241.txt","content_type":"text/plain","enriched_at":"2026-04-11T09:05:02.498030+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1802768/0001140361-26-014241.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1802768/0001140361-26-014241.txt","source_event_id":"evt_f805dc39f6b0","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"4ab7cb032ee69ef7","kind":"sec_filing","published_at":"20260410","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-10"],"entities":[{"asset_class":"equity","name":"Royalty Pharma plc","relevance":"high","symbol":"RPRX","type":"issuer_company"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the supplied text (no prior filing comparison content included).","No substantive proxy content (e.g., proposals, board actions, voting matters) is included in the provided excerpt beyond the form header/cover information.","The signal type is labeled discovery_sec_filing_delta, but the delta details (what differs from the prior state) are not present in the provided text."],"key_facts":["Form type: DEFA14A.","Filer/issuer: Royalty Pharma plc.","SEC filing date shown as 2026-04-10 (accession number 0001140361-26-014241).","Document indicates it is a Schedule 14A proxy statement under Section 14(a) of the Securities Exchange Act of 1934.","The filing is marked as \u201cDefinitive Additional Materials.\u201d","Payment of filing fee: \u201cNo fee required.\u201d","The document header shows \u201cFiled as of date: 20260410\u201d and \u201cDate as of change: 20260410.\u201d"],"numeric_claims":[{"label":"SEC filing date (as of date)","value":"2026-04-10"},{"label":"SEC accession number","value":"0001140361-26-014241"},{"label":"Public document count","value":"4"}],"primary_claim":"Royalty Pharma plc filed Form DEFA14A with the SEC on 2026-04-10 as definitive additional materials for a Schedule 14A proxy statement.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Royalty Pharma plc filed a DEFA14A (definitive additional materials) with the SEC on 2026-04-10. The filing is a Schedule 14A proxy statement amendment/additional materials submission, with no filing fee required.","topics":["SEC filing","DEFA14A","Schedule 14A","proxy statement","definitive additional materials"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 Royalty Pharma plc \u00b7 Filed 20260410","ticker":"RPRX","tickers":["RPRX"],"title":"RPRX filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/1802768/0001140361-26-014241.txt"}}
TEXT NOT NULL
source_ref
candidate:sc_2bce81754a191def
TEXT
confidence
REAL (default 0.0
dedupe_key
signal_enriched:discovery_sec_filing_delta:5f1a2e291704cfb5
TEXT
episode_id
NULL
TEXT
created_at
2026-04-11T09:05:02.498171+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel